GA (n=54) | IFNß1a-sc (n=47) | IFNß1a-im (n=73) | IFNß1b-sc (n=50) | Overall (n=224) | |
Adherence,* n(%) | 47 (87.0) | 38 (80.9) | 63 (86.3) | 33 (66.0) | 181 (80.8) |
OR† | – | 1.6 | 1.1 | 3.5 | |
95% CI | 0.54 to 4.67 | 0.38 to 3.01 | 1.29 to 9.28 | ||
p Value | 0.40 | 0.90 | 0.01 |
*Percentage of patients with adherence ≥95%.
†Risk of non-adherence vs GA.
GA, glatiramer acetate; IFNβ 1a-im, intramuscular interferon β1a; IFNβ1a-sc, subcutaneous interferon β1a; IFNβ1b-sc, subcutaneous interferon β1b.